Clinical Trial Update: Effects of Rivaroxaban on Vascular FMD in Patients With Stable Atherosclerotic Vascular Diseases [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of rivaroxaban on vascular function (flow-mediated dilation) in patients with stable atherosclerotic vascular di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: The University of Hong Kong | Conditions: Atherosclerosis, Coronary | Phase 4 | Status: COMPLETED